Gupta Phalguni, Ratner Deena, Patterson Bruce K, Kulka Kathy, Rohan Lisa C, Parniak Michael A, Isaacs Charles E, Hillier Sharon
Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.
AIDS Res Hum Retroviruses. 2006 May;22(5):419-24. doi: 10.1089/aid.2006.22.419.
Cervical tissue-based organ culture system has been used to test the cytotoxicity and antiviral activity of microbicides. One of the problems of using current organ culture methods for routine microbicide testing is the need to continually obtain fresh tissue, which can be limited in access and supply. Use of frozen tissue, stored when available and thawed when needed, would alleviate the need for constant access to new tissue. This study was designed to explore the possibility of using frozen-thawed cervical tissue to test microbicides for their anti-HIV activity. We provided biochemical, histological, and quantitative immunohistochemical data to demonstrate the integrity of the frozen-thawed organ culture system. Significant levels of HIV-1 mucosal transmission were noted with both fresh and frozen-thawed tissue, regardless of the coreceptor usage of the virus isolate. Furthermore, candidate microbicides UC781, beta-cyclodextrin, and octylglycerol inhibited HIV-1 transmission across the mucosa of frozen-thawed tissues with a level of efficiency similar to that of fresh tissues. Therefore, frozen-thawed cervical tissue in the organ culture system provides a practical and convenient model to screen topical microbicides for their ability to block sexual transmission of HIV-1, and reduces the problems associated with procurement of the numerous tissues required for evaluation and comparison of microbicide candidates among different laboratories.
基于宫颈组织的器官培养系统已被用于测试杀微生物剂的细胞毒性和抗病毒活性。使用当前器官培养方法进行常规杀微生物剂测试的一个问题是需要持续获取新鲜组织,而新鲜组织的获取和供应可能受到限制。使用冷冻组织,在有可用组织时储存,需要时解冻,将减少持续获取新组织的需求。本研究旨在探索使用冻融宫颈组织测试杀微生物剂抗HIV活性的可能性。我们提供了生化、组织学和定量免疫组化数据,以证明冻融器官培养系统的完整性。无论病毒分离株的共受体使用情况如何,新鲜组织和冻融组织均观察到显著水平的HIV-1黏膜传播。此外,候选杀微生物剂UC781、β-环糊精和辛基甘油抑制HIV-1在冻融组织黏膜中的传播,其效率水平与新鲜组织相似。因此,器官培养系统中的冻融宫颈组织为筛选局部杀微生物剂阻断HIV-1性传播的能力提供了一个实用且方便的模型,并减少了与不同实验室评估和比较候选杀微生物剂所需大量组织采购相关的问题。